Clinical Trials Directory

Trials / Terminated

TerminatedNCT00332826

Inhaled Technosphere Insulin in Subjects With Diabetes Mellitus and Asthma

A Phase 3, 12-month Treatment, Multicenter, Randomized, Open-Label, Parallel Group Clinical Trial Comparing Prandial Subcutaneous Insulin With Prandial Inhaled Technosphere Insulin in Subjects With Diabetes Mellitus and Asthma

Status
Terminated
Phase
Phase 3
Study type
Interventional
Enrollment
3 (actual)
Sponsor
Mannkind Corporation · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The clinical trial is designed to evaluate the safety of inhaled Technosphere/Insulin compared with non-inhaled anti-diabetic therapies in subjects with type 1 or type 2 diabetes mellitus and concurrent asthma.

Conditions

Interventions

TypeNameDescription
DRUGTechnosphere Insulin

Timeline

Start date
2006-06-01
Primary completion
2007-10-01
Completion
2007-10-01
First posted
2006-06-02
Last updated
2012-05-04

Locations

78 sites across 11 countries: United States, Argentina, Brazil, Canada, Czechia, Mexico, Poland, Russia, Spain, Ukraine, United Kingdom

Source: ClinicalTrials.gov record NCT00332826. Inclusion in this directory is not an endorsement.